Achieved IgG reduction is similar to that achieved by nipocalimab in human FcRn transgenic mice [360], and a concomitant therapeutic effect has been observed in animal models of arthritis, ITP and glomerulonephritis [414,415,416] and in clinical trials assessing safety (NCT01802697), increasing transplant success by negating pre-existing immunity (NCT02224820, NCT02426684, and NCT02475551), and in thrombotic thrombocytopenic purpura (NCT02854059)
Maged AM, Deeb WS, El Amir A, Zaki SS, El Sawah H, Al Mohamady M, et al
Examination and Diagnostic Testing Accurate diagnosis is the cornerstone of effective treatment
Murphy MP, Levine H (2010) Alzheimers disease and the amyloid- peptide
When you do drink, pace yourself